New sequencing tests bring new questions.By Kate Yandell
When Don Stranathan was diagnosed with stage IV non–small cell lung cancer (NSCLC) in 2009, genetic testing of NSCLC tumors was in its infancy. By 2015, when a new tumor was found in his left lung, Stranathan knew he wanted to learn as much as he could about his tumor’s genetics.
No comments:
Post a Comment